{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:47:21Z","timestamp":1791859641351,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4-6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1163\/156856003322699500","type":"journal-article","created":{"date-parts":[[2004,1,18]],"date-time":"2004-01-18T05:56:02Z","timestamp":1074405362000},"page":"323-331","source":"Crossref","is-referenced-by-count":7,"title":["Regulation of bone lysis in inflammatory diseases"],"prefix":"10.1007","volume":"11","author":[{"given":"David R.","family":"Haynes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania N.","family":"Crotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"vsp_09254692_v11n4_s4_CR1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/33.4.309","volume":"33","author":"N. Al-Saffar","year":"1994","unstructured":"Al-Saffar, N. and Revell, A. (1994). Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: A potential role in osteolysis, Br. J. Rheumatol. 33, 309\u2013316.","journal-title":"Br. J. Rheumatol."},{"key":"vsp_09254692_v11n4_s4_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.1780380202","volume":"38","author":"W. P. Arend","year":"1995","unstructured":"Arend, W. P. and Dayer, J.-M. (1995). Inhibition of the production and effects of interleukin-1 and tumor necrosis factor-\u03b1 in rheumatoid arthritis, Arthritis Rheum. 38, 151\u2013160.","journal-title":"Arthritis Rheum."},{"key":"vsp_09254692_v11n4_s4_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4049\/jimmunol.160.1.403","volume":"160","author":"R. Assuma","year":"1998","unstructured":"Assuma, R., Oates, T., Cochran, D., et al. (1998). IL-1 and TNF antagonists inhibit the inflammation response and bone loss in experimental periodontitis, J. Immununol. 160, 403\u2013409.","journal-title":"J. Immununol."},{"key":"vsp_09254692_v11n4_s4_CR4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/bbrc.1998.8993","volume":"248","author":"H. Brandstrom","year":"1998","unstructured":"Brandstrom, H., Jonsson, K., Vidal, O., et al. (1998). Tumor necrosis factor-\u03b1 and-\u03b2 upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells, Biochem. Biophys. Res. Commun. 248, 454\u2013457.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"vsp_09254692_v11n4_s4_CR5","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N. Bucay","year":"1998","unstructured":"Bucay, N., Sarosi, I., Dunstan, C. R., et al. (1998). Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification, Genes Dev. 12, 1260\u20131268.","journal-title":"Genes Dev."},{"key":"vsp_09254692_v11n4_s4_CR6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.1780340908","volume":"34","author":"C. Q. Chu","year":"1991","unstructured":"Chu, C. Q., Field, M., Feldman, M., et al. (1991). Localization of tumor necrosis factor a in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis, Arthritis Rheum. 34, 1125\u20131132.","journal-title":"Arthritis Rheum."},{"key":"vsp_09254692_v11n4_s4_CR7","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.1074\/jbc.M010153200","volume":"276","author":"P. Col lin-Osdoby","year":"2001","unstructured":"Col lin-Osdoby, P., Rothe, L., Anderson, F., et al. (2001). Receptor activator of NF-\u03baB and osteoprote-gerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis, J. Biol. Chem. 276, 20659\u201320672.","journal-title":"J. Biol. Chem."},{"key":"vsp_09254692_v11n4_s4_CR8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1034\/j.1600-0765.2003.00615.x","volume":"38","author":"T. N. Crotti","year":"2003","unstructured":"Crotti, T. N., Smith, M. D., Hirsch, R. S., et al. (2003). Receptor activator NF-\u03ba B ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis, J. Periodontol. Res. 38, 380\u2013387.","journal-title":"J. Periodontol. Res"},{"key":"vsp_09254692_v11n4_s4_CR9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.61.12.1047","volume":"61","author":"T. N. Crotti","year":"2002","unstructured":"Crotti, T. N., Smith, M. D., Weedon, H., et al. (2002). Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis, Ann. Rheum. Dis. 61, 1047\u20131054.","journal-title":"Ann. Rheum. Dis."},{"key":"vsp_09254692_v11n4_s4_CR10","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1210\/en.137.9.4058","volume":"137","author":"Y. Fujikawa","year":"1996","unstructured":"Fujikawa, Y., Quinn, J. M. W., Sabokbar, A., et al. (1996a). The human osteoclast precursor circulates in the monocyte fraction, Endocrinology 137, 4058\u20134060.","journal-title":"Endocrinology"},{"key":"vsp_09254692_v11n4_s4_CR11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/ard.55.11.816","volume":"55","author":"Y. Fujikawa","year":"1996","unstructured":"Fujikawa, Y., Sabokbar, A., Neale, S. D., et al. (1996b). Human osteoclast formation and bone resorption by monoytes and synovial macrophages in rheumatoid arthritis, Ann. Rheum. Dis. 55, 816\u2013822.","journal-title":"Ann. Rheum. Dis."},{"key":"vsp_09254692_v11n4_s4_CR12","first-page":"97","volume":"192","author":"Y. Fujikawa","year":"1996","unstructured":"Fujikawa, Y., Shingu, M., Torisu, T., et al. (1996c). Bone resorption by tartrate-resistant acid phosphatase-positivemultinuclear cells isolated fromrheumatoidsynovium, Br. J. Rheumatol. 192, 97\u2013104.","journal-title":"Br. J. Rheumatol."},{"key":"vsp_09254692_v11n4_s4_CR13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1902\/jop.1993.64.10.980","volume":"64","author":"M. Geivelis","year":"1993","unstructured":"Geivelis, M., Turner, D. W., Pederson, E. D., et al. (1993). Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease, J. Periodontol. 64, 980\u2013983.","journal-title":"J. Periodontol."},{"key":"vsp_09254692_v11n4_s4_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11926-002-0069-y","volume":"4","author":"S. R. Goldring","year":"2002","unstructured":"Goldring, S. R. and Gravallese, E. M. (2002). Pathogenesis of bone lesions in rheumaotid arthritis, Curr. Rheum. Rep. 4, 226\u2013231.","journal-title":"Curr. Rheum. Rep."},{"key":"vsp_09254692_v11n4_s4_CR15","first-page":"1282","volume":"25","author":"A. Gough","year":"1998","unstructured":"Gough, A., Sambrook, P., Devlin, J., et al. (1998). Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis, J. Rheumatol. 25, 1282\u20131289.","journal-title":"J. Rheumatol."},{"key":"vsp_09254692_v11n4_s4_CR16","first-page":"943","volume":"152","author":"E. M. Gravallese","year":"1998","unstructured":"Gravallese, E. M., Harada, Y., Wang, J.-T., et al. (1998). Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis, Am. J. Pathol. 152, 943\u2013951.","journal-title":"Am. J. Pathol."},{"key":"vsp_09254692_v11n4_s4_CR17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S8756-3282(99)00176-3","volume":"25","author":"D. R. Haynes","year":"1999","unstructured":"Haynes, D. R., Atkins, G. J., Loric, M., et al. (1999). Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation, Bone 25, 269\u2013278.","journal-title":"Bone"},{"key":"vsp_09254692_v11n4_s4_CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/rheumatology\/keg047","volume":"42","author":"D. R. Haynes","year":"2003","unstructured":"Haynes, D. R., Barg, E., Crotti, T. N., et al. (2003a). Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls, Rheumatology 42, 123\u2013134.","journal-title":"Rheumatology"},{"key":"vsp_09254692_v11n4_s4_CR19","first-page":"1","volume":"43","author":"D. R. Haynes","year":"2003","unstructured":"Haynes, D. R., Barg, E., Crotti, T. N., et al. (2003b). Osteoprotegerin (OPG) Expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies, osteoarthritis and normal controls, Rheumatology 43, 1\u201312.","journal-title":"Rheumatology"},{"key":"vsp_09254692_v11n4_s4_CR20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/rheumatology\/40.6.623","volume":"40","author":"D. R. Haynes","year":"2001","unstructured":"Haynes, D. R., Crotti, T. N., Loric, M., et al. (2001a). Osteoprotegerinand receptor activator of nuclear factor kappa B ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint, J. Rheumatol. 40, 623\u2013630.","journal-title":"J. Rheumatol."},{"key":"vsp_09254692_v11n4_s4_CR21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1302\/0301-620X.83B6.10905","volume":"83B","author":"D. R. Haynes","year":"2001","unstructured":"Haynes, D. R., Crotti, T. N., Potter, A. E., et al. (2001b). The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis, J. Bone Joint Surg. 83B, 902\u2013911.","journal-title":"J. Bone Joint Surg."},{"key":"vsp_09254692_v11n4_s4_CR22","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1302\/0301-620X.79B6.7832","volume":"79B","author":"D. R. Haynes","year":"1997","unstructured":"Haynes, D. R., Hay, S. J., Rogers, S. D., et al. (1997). Regulation of bone cells by particle-activated mononuclear phagocytes, J. Bone Joint Surg. 79B, 988\u2013994.","journal-title":"J. Bone Joint Surg."},{"key":"vsp_09254692_v11n4_s4_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","volume":"25","author":"L. C. Hofbauer","year":"1999","unstructured":"Hofbauer, L. C., Lacey, D. L., Dunstan, C. R., et al. (1999). Interleukin-1\u03b2 and tumor necrosis factor-\u03b1, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells, Bone 25, 255\u2013259.","journal-title":"Bone"},{"key":"vsp_09254692_v11n4_s4_CR24","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/en.139.11.4743","volume":"139","author":"N. J. Horwood","year":"1998","unstructured":"Horwood, N. J., Elliot, J., Martin, T. J., et al. (1998). Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells, Endocrinology 139, 4743\u20134746.","journal-title":"Endocrinology"},{"key":"vsp_09254692_v11n4_s4_CR25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/ard.59.1.26","volume":"59","author":"I. Itonaga","year":"2000","unstructured":"Itonaga, I., Sabokbar, A., Murray, D. W., et al. (2000a). Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages, Ann. Rheum. Dis. 59, 26\u201331.","journal-title":"Ann. Rheum. Dis."},{"key":"vsp_09254692_v11n4_s4_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH672>3.0.CO;2-W","volume":"192","author":"Y. Itonaga","year":"2000","unstructured":"Itonaga, Y., Fujikawa, Y., Sabokbar, A., et al. (2000b). Rheumatoid arthritis synovial macrophage osteoclast differentiationis osteoprotegerin ligand-dependent, J. Pathol. 192, 97\u2013104.","journal-title":"J. Pathol."},{"key":"vsp_09254692_v11n4_s4_CR27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1302\/0301-620X.76B3.8175849","volume":"76B","author":"R. Johnsson","year":"1994","unstructured":"Johnsson, R., Franzen, H. and Nilsson, L. T. (1994). Combined survivorshipand multivariate analysis of revisions in 799 hip prostheses: a 10-to 20-year review of mechanical loosening, J. Bone Joint Surg. 76B, 439\u2013443.","journal-title":"J. Bone Joint Surg."},{"key":"vsp_09254692_v11n4_s4_CR28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K. Kobayashi","year":"2000","unstructured":"Kobayashi, K., Takahashi, N., Jimi, E., et al. (2000). Tumor necrosis factor \u03b1 stimulates osteoclast differentiationby a mechanism independent of the ODF\/ RANKL-RANK interaction, J. Exp. Med. 191, 275\u2013285.","journal-title":"J. Exp. Med."},{"key":"vsp_09254692_v11n4_s4_CR29","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1084\/jem.173.5.1291","volume":"173","author":"H. Kodama","year":"1991","unstructured":"Kodama, H., Nose, M., Niida, S., et al. (1991). Essential role of macrophage colony-stimultingfactor in the osteoclast differentiationsupported by stromal cells, J. Exp. Med. 173, 1291\u20131294.","journal-title":"J. Exp. Med."},{"key":"vsp_09254692_v11n4_s4_CR30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"Y.-Y. Kong","year":"1999","unstructured":"Kong, Y.-Y., Feige, U., Sarosi, I., et al. (1999a). Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand, Nature 402, 304\u2013309.","journal-title":"Nature"},{"key":"vsp_09254692_v11n4_s4_CR31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"Y.-Y. Kong","year":"1999","unstructured":"Kong, Y.-Y., Yoshida, H., Sarosi, I., et al. (1999b). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature 397, 315\u2013323.","journal-title":"Nature"},{"key":"vsp_09254692_v11n4_s4_CR32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650110113","volume":"11","author":"S. Kotake","year":"1996","unstructured":"Kotake, S., Sato, K., Kim, K. J., et al. (1996). Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-likecell formation, J. Bone Miner. Res. 11, 88\u201395.","journal-title":"J. Bone Miner. Res."},{"key":"vsp_09254692_v11n4_s4_CR33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"D. L. Lacey","year":"1998","unstructured":"Lacey, D. L., Timms, E., Tan, H.-L., et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiationand activation, Cell 93, 165\u2013176.","journal-title":"Cell"},{"key":"vsp_09254692_v11n4_s4_CR34","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J. Lam","year":"2000","unstructured":"Lam, J., Takeshita, S., Barker, J. E., et al. (2000). TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand, J. Clin. Invest. 106, 1481\u20131488.","journal-title":"J. Clin. Invest."},{"key":"vsp_09254692_v11n4_s4_CR35","first-page":"17","volume":"11","author":"D. Liu","year":"2003","unstructured":"Liu, D., Xu, J.K., Figliomeni, L., et al. (2003). Expression of RANKL and OPG in mRNA in periodontal disease: possible involvement in bone destruction, Int. J. Mol. Med. 11, 17\u201321.","journal-title":"Int. J. Mol. Med."},{"key":"vsp_09254692_v11n4_s4_CR36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jcb.240560312","volume":"56","author":"T. J. Martin","year":"1994","unstructured":"Martin, T. J. and Ng, K. W. (1994). Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity, J. Cell Biochem. 56, 357\u2013366.","journal-title":"J. Cell Biochem."},{"key":"vsp_09254692_v11n4_s4_CR37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9440(10)65266-2","volume":"154","author":"K. D. Merkel","year":"1999","unstructured":"Merkel, K. D., Erdmann, J. M., Mchugh, K. P., et al. (1999). Tumor necrosis factor-\u03b1 mediates orthopedic implant osteolysis, Am. J. Pathol. 154, 203\u2013210.","journal-title":"Am. J. Pathol."},{"key":"vsp_09254692_v11n4_s4_CR38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","volume":"247","author":"A. Mizuno","year":"1998","unstructured":"Mizuno, A., Amizuka, N., Irie, K., et al. (1998). Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/ osteoprotegerin, Biochem. Biophys. Res. Commun. 247, 610\u2013615.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"vsp_09254692_v11n4_s4_CR39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","volume":"275","author":"T. Nakashima","year":"2000","unstructured":"Nakashima, T., Kobayashi, Y., Yamasaki, S., et al. (2000). Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-\u03baB ligand: modulation of the expression by osteotropic factors and cytokines, Biochem. Biophys. Res. Commun. 275, 768\u2013775.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"vsp_09254692_v11n4_s4_CR40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00002281-200305000-00016","volume":"15","author":"T. Nakashima","year":"2003","unstructured":"Nakashima, T. Wada, T. and Penninger, J. M. (2003). RANKL and RANK as novel therapeutic targets for arthritis, Curr. Opin. Rheumatol. 15, 280\u2013287.","journal-title":"Curr. Opin. Rheumatol."},{"key":"vsp_09254692_v11n4_s4_CR41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/jor.1100170510","volume":"17","author":"S. Neale","year":"1999","unstructured":"Neale, S., Sabokbar, A., Howie, D. W., et al. (1999). Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption, J. Orthoped. Res. 17, 686\u2013694.","journal-title":"J. Orthoped. Res."},{"key":"vsp_09254692_v11n4_s4_CR42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s002239900473","volume":"62","author":"J. M. W. Quinn","year":"1998","unstructured":"Quinn, J. M. W., Neale, S. D., Fujikawa, Y., et al. (1998). Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells, Calcif. Tissue Int. 62, 527\u2013531.","journal-title":"Calcif. Tissue Int."},{"key":"vsp_09254692_v11n4_s4_CR43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02411258","volume":"34","author":"G. A. Rodan","year":"1982","unstructured":"Rodan, G. A. and Martin, T. J. (1982). Role of osteoblasts in hormonal control of bone resorption -- a hypothesis, Calcif. Tissue Int. 34, 311.","journal-title":"Calcif. Tissue Int."},{"key":"vsp_09254692_v11n4_s4_CR44","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T","volume":"43","author":"E. Romas","year":"2000","unstructured":"Romas, E., Bakharevski, O., Hards, D. K., et al. (2000). Expression of osteoclast differentiationfactor at sites of bone resorption in collagen-inducedarthritis, Arthritis Rheum. 43, 821\u2013826.","journal-title":"Arthritis Rheum."},{"key":"vsp_09254692_v11n4_s4_CR45","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.56.7.414","volume":"56","author":"A. Sabokbar","year":"1997","unstructured":"Sabokbar, A., Fujukawa, Y., Neale, S., et al. (1997). Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells, Ann. Rheum. Dis. 56, 414\u2013420.","journal-title":"Ann. Rheum. Dis."},{"key":"vsp_09254692_v11n4_s4_CR46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0736-0266(02)00106-7","volume":"21","author":"A. Sabokbar","year":"2003","unstructured":"Sabokbar, A., Kudo, O. and Athanasou, N. A. (2003). Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis, J. Orthoped. Res. 21, 73\u201380.","journal-title":"J. Orthoped. Res."},{"key":"vsp_09254692_v11n4_s4_CR47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0757.1997.tb00196.x","volume":"14","author":"Z. Schwartz","year":"2000","unstructured":"Schwartz, Z., Goultschin, J., Dean, D. D., et al. (2000). Mechanisms of alveolar bone destruction in periodontitis, Periodontology 14, 158\u2013172.","journal-title":"Periodontology"},{"key":"vsp_09254692_v11n4_s4_CR48","doi-asserted-by":"crossref","first-page":"87S","DOI":"10.1016\/8756-3282(95)00185-G","volume":"17","author":"T. Suda","year":"1995","unstructured":"Suda, T., Udagawa, N., Nakamura, I., et al. (1995). Modulation of osteoclast differentiation by local factors, Bone 17, 87S\u201391S.","journal-title":"Bone"},{"key":"vsp_09254692_v11n4_s4_CR49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/rheumatology\/40.6.673","volume":"40","author":"Y. Suzuki","year":"2001","unstructured":"Suzuki, Y., Tsutsumi, Y., Nakagawa, M., et al. (2001). Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium, Rheumatology 40, 673\u2013682.","journal-title":"Rheumatology"},{"key":"vsp_09254692_v11n4_s4_CR50","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","volume":"123","author":"N. Takahashi","year":"1988","unstructured":"Takahashi, N., Akatsu, T., Udagawa, N., et al. (1988). Osteoblastic cells are involved in osteoclast formation, Endocrinology 123, 2600\u20132602.","journal-title":"Endocrinology"},{"key":"vsp_09254692_v11n4_s4_CR51","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","volume":"416","author":"H. Takayanagi","year":"2002","unstructured":"Takayanagi, H., Kim, S., Matsuo, K., et al. (2002). RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta, Nature 416, 744\u2013749.","journal-title":"Nature"},{"key":"vsp_09254692_v11n4_s4_CR52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1097-4652(199810)177:1<26::AID-JCP3>3.0.CO;2-G","volume":"177","author":"T. Tsurakai","year":"1998","unstructured":"Tsurakai, T., Takahashi, N., Jimi, E., et al. (1998). Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time, J. Cell Physiol. 177, 26\u201335.","journal-title":"J. Cell Physiol."},{"key":"vsp_09254692_v11n4_s4_CR53","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1073\/pnas.87.18.7260","volume":"87","author":"N. Udagawa","year":"1990","unstructured":"Udagawa, N., Takahashi, N., Akatsu, T., et al. (1990). Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells, Proc. Natl. Acad. Sci. USA 87, 7260\u20137264.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"vsp_09254692_v11n4_s4_CR54","first-page":"643","volume":"14","author":"J. W. Xu","year":"1996","unstructured":"Xu, J. W., Konttinen, Y. T., Lassus, J., et al. (1996). Tumour necrosis factor-alpha (TNF-alpha) in loosening of total hip replacement (THR), Clin. Exp. Rheumatol 14, 643\u2013648.","journal-title":"Clin. Exp. Rheumatol"},{"key":"vsp_09254692_v11n4_s4_CR55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/03009749850154393","volume":"27","author":"J. W. Xu","year":"1998","unstructured":"Xu, J. W., Li, T.-F., Partsch, G., et al. (1998). Interleukin-11 (IL-11) in aseptic loosening of total hip replacement (THR), Scand. J. Rheumatol. 27, 363\u2013367.","journal-title":"Scand. J. Rheumatol."},{"key":"vsp_09254692_v11n4_s4_CR56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0714.1994.tb00074.x","volume":"23","author":"K. Yamazaki","year":"1994","unstructured":"Yamazaki, K., Nakajima, T., Gemmell, E., et al. (1994). IL-4 and IL-6-producing cells in human periodontal disease tissue, J. Oral Pathol. Med. 23, 347\u2013353.","journal-title":"J. Oral Pathol. Med."},{"key":"vsp_09254692_v11n4_s4_CR57","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/en.139.3.1329","volume":"139","author":"H. Yasuda","year":"1998","unstructured":"Yasuda, H., Shima, N., Nakagawa, N., et al. (1998a). Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG\/ OCIF inhibits osteoclastogenesis in vitro, Endocrinology 139, 1329\u20131337.","journal-title":"Endocrinology"},{"key":"vsp_09254692_v11n4_s4_CR58","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H. Yasuda","year":"1998","unstructured":"Yasuda, H., Shima, N., Nakagawa, N., et al. (1998b). Osteoclast differentiation factor is a ligand for osteoprotegerin\/ osteoclast inhibitory factor and is identical to TRANCE\/ RANKL, Proc. Natl. Acad. Sci. USA 95, 3597\u20133602.","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["InflammoPharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1163\/156856003322699500.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T19:17:46Z","timestamp":1682623066000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1163\/156856003322699500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":58,"journal-issue":{"issue":"4-6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["vsp_09254692_v11n4_s4"],"URL":"https:\/\/doi.org\/10.1163\/156856003322699500","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}